© The Rockefeller University Press,
0021-9525/1998//241 $5.00
The Journal of Cell Biology, Volume 142, Number 1,
, 1998 241-250
The FGF Receptor–1 Tyrosine Kinase Domain Regulates Myogenesis but Is Not Sufficient to Stimulate Proliferation
Arthur J. Kudla
,
Nathan C. Jones*,
R. Scott Rosenthal*,
Kirstin Arthur||,
Kari L. Clase
, and
Bradley B. Olwin*
* Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado 80309, and the Walther Cancer Institute, Indianapolis, Indiana 47238;
Department of Biological Sciences,
Department of Basic Medical Sciences, and || Department of Biochemistry, Purdue University, West Lafayette, Indiana 47907
Ligand-stimulated activation of FGF receptors (FGFRs) in skeletal muscle cells represses terminal myogenic differentiation. Skeletal muscle cell lines and subsets of primary cells are dependent on FGFs to repress myogenesis and maintain growth. To understand the intracellular events that transduce these signals, MM14 skeletal muscle cells were transfected with expression vectors encoding chimeric receptors. The chimeras are comprised of the PDGF β receptor (PDGFβR) extracellular domain, the FGFR-1 intracellular domain, and either the PDGFβR or FGFR-1 transmembrane domain. The chimeric receptors were autophosphorylated upon PDGF-BB stimulation and are capable of stimulating mitogen-activated protein kinase activity. Activation of the tyrosine kinase domain of either chimera repressed myogenesis, suggesting intracellular responses regulating skeletal muscle differentiation are transduced by activation of the FGFR-1 tyrosine kinase. Unexpectedly, we found that activation of either chimeric receptor failed to stimulate cellular proliferation. Thus, it appears that regulation of skeletal muscle differentiation by FGFs requires only activation of the FGFR tyrosine kinase. In contrast, stimulation of proliferation may require additional, as yet unidentified, signals involving the receptor ectodomain, the FGF ligand, and heparan sulfate either alone, or in combination.
Key Words: skeletal muscle differentiation fibroblast growth factor myogenesis tyrosine kinase
Abbreviations used in this paper: BrdU, 5-bromo-2 deoxyuridine; CMV, cytomegalovirus; ERK, extracellular-regulated kinase; FGFR, FGF receptor; MAPK, mitogen-activated protein kinase; MBP, myelin basic protein; MHC, myosin heavy chain; PDGFβR, PDGF β receptor; PRtm/FR1, PDGFβR/FGFR-1 chimera with PDGFβR transmembrane domain; PR/ FR1tm, PDGFβR/FGFR-1 chimera with FGFR-1 transmembrane domain; RT, reverse transcription; TPA, 12-O-tetra-decnoylphorbol-13-acetate.
Address all correspondence to Bradley B. Olwin, Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309. Tel.: (303) 492-6816. Fax: (303) 492-1587. E-mail: Bradley.Olwin{at}colorado.edu

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Olguin, H. C., Yang, Z., Tapscott, S. J., Olwin, B. B.
(2007). Reciprocal inhibition between Pax7 and muscle regulatory factors modulates myogenic cell fate determination. JCB
177: 769-779
[Abstract]
[Full Text]
-
de Alvaro, C., Martinez, N., Rojas, J. M., Lorenzo, M.
(2005). Sprouty-2 Overexpression in C2C12 Cells Confers Myogenic Differentiation Properties in the Presence of FGF2. Mol. Biol. Cell
16: 4454-4461
[Abstract]
[Full Text]
-
Kontaridis, M. I., Liu, X., Zhang, L., Bennett, A. M.
(2002). Role of SHP-2 in Fibroblast Growth Factor Receptor-Mediated Suppression of Myogenesis in C2C12 Myoblasts. Mol. Cell. Biol.
22: 3875-3891
[Abstract]
[Full Text]
-
Fedorov, Y. V., Jones, N. C., Olwin, B. B.
(2002). Atypical Protein Kinase Cs Are the Ras Effectors That Mediate Repression of Myogenic Satellite Cell Differentiation. Mol. Cell. Biol.
22: 1140-1149
[Abstract]
[Full Text]
-
Kahane, N., Cinnamon, Y., Bachelet, I., Kalcheim, C.
(2001). The third wave of myotome colonization by mitotically competent progenitors: regulating the balance between differentiation and proliferation during muscle development. Development
128: 2187-2198
[Abstract]
[Full Text]
-
Fedorov, Y. V., Rosenthal, R. S., Olwin, B. B.
(2001). Oncogenic Ras-Induced Proliferation Requires Autocrine Fibroblast Growth Factor 2 Signaling in Skeletal Muscle Cells. JCB
152: 1301-1306
[Abstract]
[Full Text]
-
Vaccarino, F. M.
(2000). Stem Cells and Neuronal Progenitors and Their Diversity in the CNS: Are Time and Place Important?. Neuroscientist
6: 338-352
[Abstract]
-
Kästner, S., Elias, M. C., Rivera, A. J., YablonkaReuveni, Z.
(2000). Gene Expression Patterns of the Fibroblast Growth Factors and Their Receptors During Myogenesis of Rat Satellite Cells. J. Histochem. Cytochem.
48: 1079-1096
[Abstract]
[Full Text]
-
BAILLY, K., SOULET, F., LEROY, D., AMALRIC, F., BOUCHE, G.
(2000). Uncoupling of cell proliferation and differentiation activities of basic fibroblast growth factor. FASEB J.
14: 333-344
[Abstract]
[Full Text]
-
Fedorov, Y. V., Jones, N. C., Olwin, B. B.
(1998). Regulation of Myogenesis by Fibroblast Growth Factors Requires Beta-Gamma Subunits of Pertussis Toxin-Sensitive G Proteins. Mol. Cell. Biol.
18: 5780-5787
[Abstract]
[Full Text]
-
Whitney, M. L., Otto, K. G., Blau, C. A., Reinecke, H., Murry, C. E.
(2001). Control of Myoblast Proliferation with a Synthetic Ligand. J. Biol. Chem.
276: 41191-41196
[Abstract]
[Full Text]